The Impact of Baseline Sleep as a Potential Moderator of Weight Loss Intervention in Breast Cancer Survivors: Results From the POWER ‐Remote Trial
Obesity · 2026
DOI: 10.1002/oby.70096 ↗At a glance
Randomisierte kontrollierte Studie in Obesity, 2026. Written by Jennifer Y Sheng and 7 co-authors. Institution: Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Major MEDLINE topics: Breast Neoplasms, Weight Loss, Sleep, Sleep Wake Disorders. Cited 3 times so far (Crossref); 44 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: NCI NIH HHS, Breast Cancer Research Foundation, Cigarette Restitution Fund at Johns Hopkins.
Abstract (original language)
Objective
We evaluated whether sleep disturbance moderates weight loss in breast cancer survivors. We hypothesized that poor sleep prior to behavioral weight loss (BWL) would be associated with less weight reduction than better sleep.
Methods
Women with prior stage 0‐III breast cancer with BMI ≥ 25 kg/m 2 were randomized to BWL ( n = 47) or self‐directed approach ( n = 46). Weight and self‐reported sleep (NIH PROMIS Adult Sleep Disturbance Short Form) were collected at baseline and at 6 and 12 months. In the full sample and cohorts stratified by baseline sleep, multiple regression analyses evaluated associations of study arm, age, baseline sleep, and BMI with weight loss.
Results
There was significant interaction between baseline sleep and treatment (BWL vs. self‐directed) for weight loss at 6 ( p = 0.024) and 12 months ( p = 0.019). Weight loss among better sleepers was −6.16% (SE 1.42%) in BWL versus self‐directed arms and −7.53% (SE 2.02%) at 6 ( p < 0.001) and 12 months ( p = 0.001), respectively. Among poor sleepers, weight loss was −3.15% (SE: 1.58%) and −2.44% (SE: 2.40%) at 6 ( p = 0.056) and 12 months ( p = 0.321), respectively. BWL had a greater effect among better sleepers but minimal effect among poor sleepers.
Conclusions
BWL has greater effects in breast cancer survivors with better versus worse sleep. Studies should evaluate whether sleep disturbance treatment augments weight loss. Trial Registration: ClinicalTrials.gov identifier NCT01871116
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
ORCID profiles: Jennifer Y Sheng
Funding
- NCI NIH HHS
- Breast Cancer Research Foundation
- Cigarette Restitution Fund at Johns Hopkins
- Clinical Center
Cite
APA
Sheng, J. Y., Chen, R., Rosner, G. L., Snyder, C. F., Appel, L. J., Stearns, V., Smith, M. T., & Coughlin, J. W. (2026). The Impact of Baseline Sleep as a Potential Moderator of Weight Loss Intervention in Breast Cancer Survivors: Results From the POWER ‐Remote Trial. Obesity. https://doi.org/10.1002/oby.70096
Vancouver
Sheng JY, Chen R, Rosner GL, Snyder CF, Appel LJ, Stearns V, et al. The Impact of Baseline Sleep as a Potential Moderator of Weight Loss Intervention in Breast Cancer Survivors: Results From the POWER ‐Remote Trial. Obesity. 2026. doi:10.1002/oby.70096
BibTeX
@article{Sheng2026,
author = {Sheng, Jennifer Y and Chen, Ruizhe and Rosner, Gary L and Snyder, Claire F and Appel, Lawrence J and Stearns, Vered and Smith, Michael T and Coughlin, Janelle W},
title = {The Impact of Baseline Sleep as a Potential Moderator of Weight Loss Intervention in Breast Cancer Survivors: Results From the POWER ‐Remote Trial},
journal = {Obesity},
year = {2026},
doi = {10.1002/oby.70096}
}
EUVIMED